Pepgen Inc. (PEPG) — 10-Q Filings

10-Q Filings (6)

• PepGen's Net Loss Widens to $71.3M, Cash Boosted by $107.6M Offering — Nov 12, 2025 Risk: high
  PepGen Inc. reported a net loss of $71.3 million for the nine months ended September 30, 2025, an increase from a net loss of $67.7 million for the same period
• PepGen's Q2 Loss Widens Amid R&D Ramp-Up, Cash Burn Accelerates — Aug 7, 2025 Risk: high
  PepGen Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with its clinical-stage biotechnology status. The company's net los
• PepGen Inc. Q1 2025 10-Q Filing — May 8, 2025 Risk: medium
  PepGen Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial activities, including research and development expenses a
• PepGen Inc. Files Q3 2024 10-Q Report — Nov 7, 2024 Risk: medium
  PepGen Inc. filed its 10-Q for the period ending September 30, 2024. The company reported on its financial performance and business operations. Key financial da
• PepGen Files 10-Q: Q2 R&D Expenses and Equity Details — Aug 8, 2024 Risk: medium
  PepGen Inc. filed its 10-Q for the period ending June 30, 2024. The company reported research and development expenses for the second quarter of 2024 and the fi
• PepGen Inc. Files 10-Q for Period Ending March 31, 2024 — May 14, 2024 Risk: low
  PepGen Inc. (PEPG) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. PepGen Inc. filed a 10-Q for the period ending March 31, 2024. The filing inclu

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX